Roche will publish its Full Year Results for 2020 prior to the opening of the Swiss Stock Exchange on Thursday, 4 February 2021. 07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before) Release will be e-mailed and posted on the Roche IR website >click here Presentation slides will be posted on the Roche IR website >click here 14:00 - 16:00 CET / 13:00 - 15:00 GMT 08:00 - 10:00 AM EST / 05:00 - 07:00 AM PST The webinar will start with presentations by senior management, followed by a Q&A session. Presenters:
Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webcast will be available via >ir.roche.com *privacy notice Best regards, Karl Mahler Head of Investor Relations and Roche Group Planning |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 28 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 January 2021 09:03:02 UTC.